Works matching AU Bolli, Geremia B.

Results: 107

Treatment responses to basal insulin glargine 300 U/ml and glargine 100 U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trial.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 503, doi. 10.1111/dom.15336

By:

Landgraf, Wolfgang;
Owens, David R.;
Frier, Brian M.;
Bolli, Geremia B.

Publication type:

Article

A comparison of the effectiveness and safety of insulin glargine 300 U/ml versus 100 U/ml in children and adolescents with newly diagnosed type 1 diabetes: A retrospective, observational, short‐term study.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2474, doi. 10.1111/dom.14839

By:

Rabbone, Ivana;
Pozzi, Erica;
Savastio, Silvia;
Luca, Galimberti;
Elisa, Morotti;
Giulio, Frontino;
Bolli, Geremia B;
Bonfanti, Riccardo

Publication type:

Article

C‐peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 1912, doi. 10.1111/dom.14785

By:

Maddaloni, Ernesto;
Bolli, Geremia B.;
Frier, Brian M.;
Little, Randie R.;
Leslie, Richard D.;
Pozzilli, Paolo;
Buzzetti, Raffaela

Publication type:

Article

Underestimation of hypoglycaemia using patients' diaries compared with downloaded glucometer data: an ITAS post hoc analysis.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 327, doi. 10.1111/dom.14560

By:

Buzzetti, Raffaella;
Bonadonna, Riccardo C.;
Giaccari, Andrea;
Perseghin, Gianluca;
Cucinotta, Domenico;
Fanelli, Carmine;
Avogaro, Angelo;
Aimaretti, Gianluca;
Larosa, Monica;
Pacchetti, Ilaria;
Bolli, Geremia B.

Publication type:

Article

Insulin Centennial: Milestones influencing the development of insulin preparations since 1922.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, p. 27, doi. 10.1111/dom.14587

By:

Owens, David R.;
Monnier, Louis;
Ceriello, Antonio;
Bolli, Geremia B.

Publication type:

Article

Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1588, doi. 10.1111/dom.14372

By:

Bolli, Geremia B.;
Cheng, Alice;
Charbonnel, Bernard;
Aroda, Vanita R.;
Westerbacka, Jukka;
Bosnyak, Zsolt;
Boëlle‐Le Corfec, Emmanuelle;
Rosenstock, Julio

Publication type:

Article

Equipotency of insulin glargine 300 and 100 U/mL with intravenous dosing but differential bioavailability with subcutaneous dosing in dogs.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 166, doi. 10.1111/dom.14212

By:

Werner, Ulrich;
Tennagels, Norbert;
Fanelli, Carmine G.;
Bolli, Geremia B.

Publication type:

Article

Lower risk of severe hypoglycaemia with insulin glargine 300 U/mL versus glargine 100 U/mL in participants with type 1 diabetes: A meta‐analysis of 6‐month phase 3 clinical trials.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1880, doi. 10.1111/dom.14109

By:

Danne, Thomas;
Matsuhisa, Munehide;
Sussebach, Christian;
Goyeau, Harmonie;
Lauand, Felipe;
Niemoeller, Elisabeth;
Bolli, Geremia B.

Publication type:

Article

Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trial.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1664, doi. 10.1111/dom.14065

By:

Bolli, Geremia B.;
Landgraf, Wolfgang;
Bosnyak, Zsolt;
Melas‐Melt, Lydie;
Home, Philip D.

Publication type:

Article

Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 8, p. 1369, doi. 10.1111/dom.14043

By:

Haluzík, Martin;
Cheng, Alice;
Müller‐Wieland, Dirk;
Westerbacka, Jukka;
Bosnyak, Zsolt;
Lauand, Felipe;
Melas‐Melt, Lydie;
Karalliedde, Janaka;
Rosenstock, Julio;
Bolli, Geremia B.

Publication type:

Article

The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 5, p. 743, doi. 10.1111/dom.13963

By:

Owens, David R.;
Bolli, Geremia B.

Publication type:

Article

Fasting C‐peptide, a biomarker for hypoglycaemia risk in insulin‐naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mL.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 315, doi. 10.1111/dom.13897

By:

Landgraf, Wolfgang;
Owens, David R.;
Frier, Brian M.;
Zhang, Mei;
Bolli, Geremia B.

Publication type:

Article

Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 321, doi. 10.1111/dom.13607

By:

Owens, David R.;
Landgraf, Wolfgang;
Frier, Brian M.;
Zhang, Mei;
Home, Philip D.;
Meneghini, Luigi;
Bolli, Geremia B.

Publication type:

Article

A post‐hoc pooled analysis to evaluate the risk of hypoglycaemia with insulin glargine 300 U/mL (Gla‐300) versus 100 U/mL (Gla‐100) over wider nocturnal windows in individuals with type 2 diabetes on a basal‐only insulin regimen.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 402, doi. 10.1111/dom.13515

By:

Bolli, Geremia B.;
Wysham, Carol;
Fisher, Miles;
Chevalier, Soazig;
Cali, Anna M. G.;
Leroy, Bruno;
Riddle, Matthew C.

Publication type:

Article

Hypoglycaemia risk in the first 8 weeks of titration with insulin glargine 100 U/mL in previously insulin‐naive individuals with type 2 diabetes mellitus.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 12, p. 2894, doi. 10.1111/dom.13450

By:

Frier, Brian M.;
Landgraf, Wolfgang;
Zhang, Mei;
Bolli, Geremia B.;
Owens, David R.

Publication type:

Article

Glycaemic control, hypoglycaemia, and weight change with insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Japanese adults with type 2 diabetes: A 12‐month comparison by concomitant sulphonylurea and/or glinide use.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 11, p. 2541, doi. 10.1111/dom.13414

By:

Terauchi, Yasuo;
Riddle, Matthew C.;
Hirose, Takahisa;
Koyama, Masayoshi;
Cheng, Xi;
Takahashi, Yoshinori;
Bolli, Geremia B.

Publication type:

Article

Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes ( EDITION 4).

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 1, p. 121, doi. 10.1111/dom.13048

By:

Home, Philip D.;
Bergenstal, Richard M.;
Bolli, Geremia B.;
Ziemen, Monika;
Rojeski, Maria;
Espinasse, Melanie;
Riddle, Matthew C.

Publication type:

Article

Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/ mL added to oral antidiabetes agents in type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 11, p. 1546, doi. 10.1111/dom.12966

By:

Owens, David R.;
Bolli, Geremia B.;
Charbonnel, Bernard;
Haak, Thomas;
Landgraf, Wolfgang;
Porcellati, Francesca;
Traylor, Louise;
Kautzky‐Willer, Alexandra

Publication type:

Article

Counterregulatory Mechanisms to Insulin-Induced Hypoglycemia in Humans: Relevance to the Problem of Intensive Treatment of IDDM.

Published in:

Journal of Pediatric Endocrinology & Metabolism, 1998, v. 11, p. 103, doi. 10.1515/jpem.1998.11.s1.103

By:

Bolli, Geremia B.

Publication type:

Article

The Modern Role of Basal Insulin in Advancing Therapy in People With Type 2 Diabetes.

Published in:

Diabetes Care, 2025, v. 48, n. 5, p. 671, doi. 10.2337/dci24-0104

By:

Bolli, Geremia B.;
Home, Philip D.;
Porcellati, Francesca;
Riddle, Matthew C.;
Gerstein, Hertzel C.;
Lucidi, Paola;
Fanelli, Carmine G.;
Owens, David R.

Publication type:

Article

Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128-2136.

Published in:

2021

By:

Bolli, Geremia B.;
Porcellati, Francesca;
Lucidi, Paola;
Fanelli, Carmine G.

Publication type:

Letter

Pharmacokinetic and Pharmacodynamic Head-to-Head Comparison of Clinical, Equivalent Doses of Insulin Glargine 300 units · mL<sup>-1</sup> and Insulin Degludec 100 units · mL<sup>-1</sup> in Type 1 Diabetes.

Published in:

2021

By:

Lucidi, Paola;
Candeloro, Paola;
Cioli, Patrizia;
Marinelli Andreoli, Anna;
Pascucci, Chiara;
Gambelunghe, Angela;
Bolli, Geremia B.;
Fanelli, Carmine G.;
Porcellati, Francesca

Publication type:

journal article

Switching From Insulin Bolus Treatment to GLP-1 RAs Added to Continued Basal Insulin in People With Type 2 Diabetes on Basal-Bolus Insulin.

Published in:

2020

By:

Bolli, Geremia B.;
Porcellati, Francesca;
Meier, Juris J.

Publication type:

journal article

Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U300 and Glargine U100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes.

Published in:

2019

By:

Porcellati, Francesca;
Lucidi, Paola;
Candeloro, Paola;
Cioli, Patrizia;
Andreoli, Anna Marinelli;
Curti, Gianluca;
Bolli, Geremia B.;
Fanelli, Carmine G.;
Marinelli Andreoli, Anna

Publication type:

journal article

John E. Gerich: Father of Modern Physiology of Glucose Homeostasis, Counterregulation to Hypoglycemia, and Mechanistic Treatment of Diabetes.

Published in:

2018

By:

Bolli, Geremia B.

Publication type:

journal article

More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial.

Published in:

2018

By:

Rosenstock, Julio;
Frías, Juan P.;
Roussel, Ronan;
Bolli, Geremia B.;
Cheng, Alice;
Ritzel, Robert;
Bosnyak, Zsolt;
Devisme, Christine;
Cali, Anna M.G.;
Sieber, Jochen;
Stella, Peter;
Xiangling Wang;
Wang, Xiangling

Publication type:

journal article

A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study.

Published in:

2018

By:

Ritzel, Robert;
Harris, Stewart B.;
Baron, Helen;
Florez, Hermes;
Roussel, Ronan;
Espinasse, Melanie;
Muehlen-Bartmer, Isabel;
Nianxian Zhang;
Bertolini, Monica;
Brulle-Wohlhueter, Claire;
Munshi, Medha;
Bolli, Geremia B.;
Zhang, Nianxian

Publication type:

journal article

How to Accurately Establish Pharmacokinetics/Pharmacodynamics of Long-Acting Insulins in Humans: Relevance to Biosimilar Insulins.

Published in:

2015

By:

Porcellati, Francesca;
Lucidi, Paola;
Bolli, Geremia B.;
Fanelli, Carmine G.

Publication type:

journal article

Pharmacokinetics and Pharmacodynamics of NPH Insulin in Type 1 Diabetes: The Importance of Appropriate Resuspension Before Subcutaneous Injection.

Published in:

2015

By:

Lucidi, Paola;
Porcellati, Francesca;
Andreoli, Anna Marinelli;
Carriero, Ilaria;
Candeloro, Paola;
Cioli, Patrizia;
Bolli, Geremia B.;
Fanelli, Carmine G.;
Marinelli Andreoli, Anna

Publication type:

journal article

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4).

Published in:

2015

By:

Home, Philip D.;
Bergensta, Richard M.;
Bolli, Geremia B.;
Ziemen, Monika;
Rojeski, Maria;
Espinasse, Melanie;
Riddle, Matthew C.;
Bergenstal, Richard M

Publication type:

journal article

Low Levels of Unmodified Insulin Glargine in Plasma of People With Type 2 Diabetes Requiring High Doses of Basal Insulin.

Published in:

Diabetes Care, 2015, v. 38, n. 7, p. e96, doi. 10.2337/dc14-2662

By:

Lucidi, Paola;
Porcellati, Francesca;
Yki-Järvinen, Hannele;
Riddle, Matthew C.;
Candeloro, Paola;
Andreoli, Anna Marinelli;
Bolli, Geremia B.;
Fanelli, Carmine G.

Publication type:

Article

New Long-Acting Insulin Analogs: From Clamp Studies to Clinical Practice.

Published in:

Diabetes Care, 2015, v. 38, n. 4, p. 541, doi. 10.2337/dc14-2314

By:

Bolli, Geremia B.;
DeVries, J. Hans

Publication type:

Article

Pharmacokinetics and Pharmacodynamics of Insulin Glargine Given in the Evening as Compared With in the Morning in Type 2 Diabetes.

Published in:

Diabetes Care, 2015, v. 38, n. 3, p. 503, doi. 10.2337/dc14-0649

By:

Porcellati, Francesca;
Lucidi, Paola;
Cioli, Patrizia;
Candeloro, Paola;
Marinelli Andreoli, Anna;
Marzotti, Stefania;
Ambrogi, Maura;
Bolli, Geremia B.;
Fanelli, Carmine G.

Publication type:

Article

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1)

Published in:

2014

By:

Riddle, Matthew C;
Bolli, Geremia B;
Ziemen, Monika;
Muehlen-Bartmer, Isabel;
Bizet, Florence;
Home, Philip D;
EDITION 1 Study Investigators

Publication type:

Journal Article

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1).

Published in:

Diabetes Care, 2014, v. 37, n. 10, p. 2755, doi. 10.2337/dc14-0991

By:

Riddle, Matthew C.;
Bolli, Geremia B.;
Ziemen, Monika;
Muehlen-Bartmer, Isabel;
Bizet, Florence;
Home, Philip D.

Publication type:

Article

Thirty Years of Research on the Dawn Phenomenon: Lessons to Optimize Blood Glucose Control in Diabetes.

Published in:

2013

By:

PORCELLATI, FRANCESCA;
LUCIDI, PAOLA;
BOLLI, GEREMIA B.;
FANELLI, CARMINE G.

Publication type:

Opinion

The fate of taspoglutide, a weekly GLP-1 receptor agonist, versus twice-daily exenatide for type 2 diabetes: the T-emerge 2 trial.

Published in:

2013

By:

Rosenstock, Julio;
Balas, Bogdan;
Charbonnel, Bernard;
Bolli, Geremia B;
Boldrin, Mark;
Ratner, Robert;
Balena, Raffaella;
T-emerge 2 Study Group

Publication type:

journal article

The Fate of Taspoglutide, a Weekly GLP-1 Receptor Agonist, Versus Twice-Daily Exenatide for Type 2 Diabetes.

Published in:

Diabetes Care, 2013, v. 36, n. 3, p. 498, doi. 10.2337/dc12-0709

By:

ROSENSTOCK, JULIO;
BALAS, BOGDAN;
CHARBONNEL, BERNARD;
BOLLI, GEREMIA B.;
BOLDRIN, MARK;
RATNER, ROBERT;
BALENA, RAFFAELLA

Publication type:

Article

Metabolism of Insulin Glargine After Repeated Daily Subcutaneous Injections in Subjects With Type 2 Diabetes.

Published in:

Diabetes Care, 2012, v. 35, n. 12, p. 2647, doi. 10.2337/dc12-0271

By:

LUCIDI, PAOLA;
CIOLI, PATRIZIA;
PORCELLATI, FRANCESCA;
HAHN, ANNKE;
ROSSETTI, PAOLO;
SCHMIDT, RONALD;
CANDELORO, PAOLA;
BOLLI, GEREMIA B.;
MARINELLI ANDREOLI, ANNA;
FANELLI, CARMINE G.

Publication type:

Article

Plasma Exposure to Insulin Glargine and Its Metabolites M1 and M2 After Subcutaneous Injection of Therapeutic and Supratherapeutic Doses of Glargine in Subjects With Type 1 Diabetes.

Published in:

Diabetes Care, 2012, v. 35, n. 12, p. 2626, doi. 10.2337/dc12-0270

By:

BOLLI, GEREMIA B.;
HAHN, ANNKE D.;
SCHMIDT, RONALD;
EISENBLAETTER, TANJA;
DAHMEN, RAPHAEL;
HEISE, TIM;
BECKER, REINHARD H. A.

Publication type:

Article

Differential effects of adiposity on pharmacodynamics of basal insulins NPH, glargine, and detemir in type 2 diabetes mellitus.

Published in:

2011

By:

Porcellati F;
Lucidi P;
Rossetti P;
Candeloro P;
Marinelli Andreoli A;
Marzotti S;
Cioli P;
Bolli GB;
Fanelli CG;
Porcellati, Francesca;
Lucidi, Paola;
Rossetti, Paolo;
Candeloro, Paola;
Andreoli, Anna Marinelli;
Marzotti, Stefania;
Cioli, Patrizia;
Bolli, Geremia B;
Fanelli, Carmine G

Publication type:

journal article

Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes Mellitus.

Published in:

Diabetes Care, 2011, v. 34, n. 12, p. 2521, doi. 10.2337/dc11-1064

By:

PORCELLATI, FRANCESCA;
LUCIDI, PAOLA;
ROSSETTI, PAOLO;
CANDELORO, PAOLA;
ANDREOLI, ANNA MARINELLI;
MARZOTTI, STEFANIA;
CIOLI, PATRIZIA;
BOLLI, GEREMIA B.;
FANELLI, CARMINE G.

Publication type:

Article

Pharmacokinetics and pharmacodynamics of therapeutic doses of basal insulins NPH, glargine, and detemir after 1 week of daily administration at bedtime in type 2 diabetic subjects: a randomized cross-over study.

Published in:

2011

By:

Lucidi P;
Porcellati F;
Rossetti P;
Candeloro P;
Cioli P;
Marzotti S;
Andreoli AM;
Fede R;
Bolli GB;
Fanelli CG;
Lucidi, Paola;
Porcellati, Francesca;
Rossetti, Paolo;
Candeloro, Paola;
Cioli, Patrizia;
Marzotti, Stefania;
Andreoli, Anna Marinelli;
Fede, Raffaela;
Bolli, Geremia B;
Fanelli, Carmine G

Publication type:

journal article

Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic Subjects.

Published in:

Diabetes Care, 2011, v. 34, n. 6, p. 1312, doi. 10.2337/dc10-1911

By:

LUCIDI, PAOLA;
PORCELLATI, FRANCESCA;
ROSSETTI, PAOLO;
CANDELORO, PAOLA;
CIOLI, PATRIZIA;
MARZOTTI, STEFANIA;
ANDREOLI, ANNA MARINELLI;
FEDE, RAFFAELA;
BOLLI, GEREMIA B.;
FANELLI, CARMINE G.

Publication type:

Article

Pivotal Role of Timely Basal Insulin Replacement After Metformin Failure in Sustaining Long-Term Blood Glucose Control at a Target in Type 2 Diabetes.

Published in:

Diabetes Care, 2011, v. 34, p. S220, doi. 10.2337/dc11-s224

By:

BOLLI, GEREMIA B.;
LUCIDI, PAOLA;
PORCELLATI, FRANCESCA;
FANELLI, CARMINE G.

Publication type:

Article

Hypoglycemia, Diabetes, and Cardiovascular Events.

Published in:

Diabetes Care, 2010, v. 33, n. 6, p. 1389, doi. 10.2337/dc09-2082

By:

Desouza, Cyrus V.;
Bolli, Geremia B.;
Fonseca, Vivian

Publication type:

Article

Hyperglycemia-Induced Platelet Activation in Type 2 Diabetes Is Resistant to Aspirin but Not to a Nitric Oxide-Donating Agent.

Published in:

Diabetes Care, 2010, v. 33, n. 6, p. 1262, doi. 10.2337/dc09-2013

By:

Gresele, Paolo;
Marzotti, Stefania;
Guglielmini, Giuseppe;
Momi, Stefania;
Giannini, Silvia;
Minuz, Pietro;
Lucidi, Paola;
Bolli, Geremia B.

Publication type:

Article

Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.

Published in:

2009

By:

Bolli GB;
Kerr D;
Thomas R;
Torlone E;
Sola-Gazagnes A;
Vitacolonna E;
Selam JL;
Home PD;
Bolli, Geremia B;
Kerr, David;
Thomas, Reena;
Torlone, Elisabetta;
Sola-Gazagnes, Agnès;
Vitacolonna, Ester;
Selam, Jean Louis;
Home, Philip D

Publication type:

journal article

Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes.

Published in:

Diabetes Care, 2009, v. 32, n. 7, p. 1170, doi. 10.2337/dc08-1874

By:

Bolli, Geremia B.;
Kerr, David;
Thomas, Reena;
Torlone, Elisabetta;
Sola-Gazagnes, Agnés;
Vitacolonna, Ester;
Selam, Jean Louis;
Home, Philip D.

Publication type:

Article

Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 Diabetes.

Published in:

Diabetes Care, 2008, v. 31, p. S113, doi. 10.2337/dc08-s227

By:

Rossetti, Paolo;
Porcellati, Francesca;
Bolli, Geremia B.;
Fanelli, Carmine G.

Publication type:

Article